Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOGOS trial of budesonide/glycopyrronium/formoterol MDI in uncontrolled asthma
CTR20211136Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide, glycopyrronium, formoterol in asthma, sponsored by AstraZeneca. Started Sep 2021; status: completed.
02
Drugs
budesonideglycopyrroniumformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20211136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211136.